Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC
The purpose of this study is to investigate Pharmacokinetics parameters of a single dose \[14C\] AC0010 in male Patients With Advanced NSCLC.
Carcinoma, Non-Small-Cell Lung
DRUG: AC0010
Pharmacokinetics, Cumalative excretion and Metabolite of 14C-labeled AC0010, Pharmacokinetics of 14C-labeled AC0010 Radioactivity in whole blood and plasma,Cumulative excretion of 14C-labeled AC0010 radioactivity in feces and urine,Metabolite identification of 14C-labeled AC0010 in plasma, urine and feces, up to 8 Days
Quantitative analysis of plasma concentrations of unlabeled AC0010, Quantitative analysis of plasma concentrations of unlabeled AC0010 using a validated LC-MS/MS method, up to 8 Days|Number of adverse events (AE) experienced by patients, Number of adverse events (AE) experienced by patients to assess safety and tolerability, up to 8 Days
The purpose of this study is to investigate the Absorption, Metabolism, Excretion and Pharmacokinetics of a single dose \[14C\] AC0010 in male Patients With Advanced NSCLC.